Journal article
Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Heart Failure : A Systematic Review and Meta-analysis.
Abstract
BACKGROUND: Randomized controlled trials established the cardiac protection of sodium-glucose cotransporter-2 (SGLT2) inhibitors among adults with type 2 diabetes. New evidence suggests that these results could extend to people without diabetes.
PURPOSE: To evaluate the effect of SGLT2 inhibitors in patients with heart failure, regardless of the presence of type 2 diabetes.
Authors
Zou X; Shi Q; Vandvik PO; Guyatt G; Lang CC; Parpia S; Wang S; Agarwal A; Zhou Y; Zhu Y
Journal
Annals of Internal Medicine, Vol. 175, No. 6, pp. 851–861
Publisher
American College of Physicians
Publication Date
June 2022
DOI
10.7326/m21-4284
ISSN
1056-8751